PRLD
Prelude Therapeutics Incorporated (PRLD)
$30
About Prelude Therapeutics Incorporated (PRLD)
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Details
Daily high
$1.45
Daily low
$0.94
Price at open
$0.94
52 Week High
$6.80
52 Week Low
$0.80
Market cap
71.5M
Dividend yield
0.00%
Volume
4.4M
Avg. volume
704,327
P/E ratio
-.68
Prelude Therapeutics Incorporated News
Details
Daily high
$1.45
Daily low
$0.94
Price at open
$0.94
52 Week High
$6.80
52 Week Low
$0.80
Market cap
71.5M
Dividend yield
0.00%
Volume
4.4M
Avg. volume
704,327
P/E ratio
-.68